發(fā)布時(shí)間：2018-06-05 04:29

  本文選題：前庭性偏頭痛 + 眩暈�。� 參考：《長(zhǎng)春中醫(yī)藥大學(xué)》2016年碩士論文

【摘要】：目的:觀察針刺治療前庭性偏頭痛(眩暈-風(fēng)陽(yáng)上擾型)與西醫(yī)常規(guī)治療的療效對(duì)比,初步驗(yàn)證針刺治療前庭性偏頭痛(眩暈-風(fēng)陽(yáng)上擾型)的臨床療效及安全性,為治療前庭性偏頭痛(眩暈-風(fēng)陽(yáng)上擾型)提供新思路,指導(dǎo)臨床實(shí)踐。方法:本研究采用隨機(jī)數(shù)字表法將符合納入標(biāo)準(zhǔn)和排除標(biāo)準(zhǔn)的72例前庭性偏頭痛(眩暈-風(fēng)陽(yáng)上擾型)患者隨機(jī)分為治療組與對(duì)照組。治療組36例,給予針刺治療;對(duì)照組36例,給予口服甲磺酸倍他司汀片治療。觀察治療前后中醫(yī)證候量表評(píng)分變化、眩暈障礙量表評(píng)分變化和健康狀況量表評(píng)分變化以評(píng)定其療效及安全性。治療后隨訪3個(gè)月,觀察兩組眩暈復(fù)發(fā)情況。結(jié)果:1.臨床共入組患者72例(治療組36例,脫落1例;對(duì)照組36例,脫落2例),治療前對(duì)基線資料(年齡、性別、中醫(yī)證候量表評(píng)分、眩暈障礙量表評(píng)分、健康狀況量表評(píng)分等)進(jìn)行比較,兩組具有可比性(P均0.05)。2.兩組間總有效率比較,治療組總有效率為80.00%,對(duì)照組總有效率為76.47%。兩組間總有效率比較無(wú)統(tǒng)計(jì)學(xué)意義(P0.05),說(shuō)明治療組和對(duì)照組的總有效率相似。3.治療前后,兩組中醫(yī)證侯量表評(píng)分均有改善,差異有統(tǒng)計(jì)學(xué)意義(P均0.05);治療后,兩組間中醫(yī)證侯量表評(píng)分比較有統(tǒng)計(jì)學(xué)意義(P0.05),說(shuō)明治療組優(yōu)于對(duì)照組。4.治療前后,兩組眩暈障礙量表評(píng)分均有改善,差異有統(tǒng)計(jì)學(xué)意義(P均0.05);治療后,兩組間眩暈障礙量表評(píng)分比較無(wú)統(tǒng)計(jì)學(xué)意義(P0.05),說(shuō)明治療組和對(duì)照組的眩暈障礙量表評(píng)分相似。5.治療前后,兩組健康狀況量表評(píng)分均有改善,差異有統(tǒng)計(jì)學(xué)意義(P均0.05);治療后,兩組間健康狀況量表評(píng)分比較無(wú)統(tǒng)計(jì)學(xué)意義(P0.05),說(shuō)明治療組和對(duì)照組的健康狀況量表評(píng)分相似。6.隨訪3個(gè)月后,兩組患者的眩暈復(fù)發(fā)次數(shù)、眩暈復(fù)發(fā)持續(xù)時(shí)間組間比較差異有統(tǒng)計(jì)學(xué)意義(P0.05),說(shuō)明治療組的眩暈復(fù)發(fā)狀況明顯優(yōu)于對(duì)照組。結(jié)論:針刺治療前庭性偏頭痛(眩暈-風(fēng)陽(yáng)上擾型)與口服甲磺酸倍他司汀片總療效相似,但在改善中醫(yī)證候方面針刺治療優(yōu)于口服甲磺酸倍他司汀片,且能夠減少眩暈復(fù)發(fā)次數(shù)、縮短眩暈復(fù)發(fā)持續(xù)時(shí)間,遠(yuǎn)期療效較好,值得臨床推廣。
[Abstract]:Objective: to observe the clinical efficacy and safety of acupuncture in treating vestibular migraine (vertigo-wind-yang disturbance type) and western medicine, and to preliminarily verify the clinical efficacy and safety of acupuncture in treating vestibular migraine (vertigo and wind-yang disturbance type). To provide a new idea for the treatment of vestibular migraine (vertigo-wind-yang disturbance) and guide clinical practice. Methods: in this study, 72 patients with vestibular migraine (vertigo-wind-yang disturbance) were randomly divided into treatment group and control group. 36 cases in the treatment group were treated with acupuncture and 36 cases in the control group were treated with oral betastatin mesylate tablets. The changes of TCM syndrome scale, vertigo disorder scale and health status scale were observed before and after treatment to evaluate the efficacy and safety. The patients were followed up for 3 months to observe the recurrence of vertigo in the two groups. The result is 1: 1. There were 72 patients (36 cases in the treatment group, 1 case in the control group, 2 cases in the control group). The baseline data (age, sex, TCM syndromes scale, vertigo disorder scale) were evaluated before treatment. Health status scale scores were compared, the two groups were comparable P 0.05. 2. The total effective rate was 80.00g in the treatment group and 76.47 in the control group. There was no significant difference between the two groups in the total effective rate (P 0.05), indicating that the total effective rate of the treatment group and the control group was similar to that of the control group. 3. Before and after treatment, the scores of TCM syndromes scale were improved in both groups, and the difference was statistically significant (P < 0.05). After treatment, the scores of TCM syndromes scale in the two groups were significantly higher than those in the control group (P 0.05), indicating that the treatment group was superior to the control group (.4). Before and after treatment, the dizziness scale scores of the two groups were improved, the difference was statistically significant (P < 0.05), and after treatment, there was no significant difference between the two groups (P 0.05), which indicated that the dizziness scale scores of the treatment group and the control group were similar to that of the control group. Before and after treatment, the health status scale scores of the two groups were improved, the difference was statistically significant (P < 0.05), and after treatment, there was no significant difference between the two groups (P 0.05), which indicated that the health status scale scores of the treatment group and the control group were similar to that of the control group. After 3 months follow-up, there were significant differences in the number of recurrent vertigo and the duration of vertigo recurrence between the two groups, indicating that the vertigo recurrence status in the treatment group was significantly better than that in the control group. Conclusion: the total curative effect of acupuncture on vestibular migraine (vertigo-wind-yang disturbance type) is similar to that of oral betastine mesylate tablet, but acupuncture is superior to oral betastatin mesylate tablet in improving TCM syndrome. It can reduce the number of recurrence of vertigo and shorten the duration of recurrence of vertigo.
【學(xué)位授予單位】：長(zhǎng)春中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類(lèi)號(hào)】：R246.6

【相似文獻(xiàn)】

相關(guān)期刊論文 前7條

1 宋莉娟;;羚珠腦舒丸治療風(fēng)陽(yáng)上擾型眩暈324例臨床觀察[J];中醫(yī)臨床研究;2013年18期

2 劉志安;針刺治療風(fēng)陽(yáng)上擾眩暈[J];中醫(yī)藥研究;1999年05期

3 劉文童;羚芎膠囊治療風(fēng)陽(yáng)上擾絡(luò)脈不和偏頭痛45例[J];湖北中醫(yī)雜志;2003年10期

4 王艷昕;陳懷珍;楊興濤;鮑遠(yuǎn)程;蔡永亮;張波;汪瀚;;羚芎膠囊治療風(fēng)陽(yáng)上擾、絡(luò)脈不和型偏頭痛64例[J];中醫(yī)藥臨床雜志;2006年06期

5 楊繼蓀;偏頭痛驗(yàn)案二例[J];浙江中醫(yī)學(xué)院學(xué)報(bào);1988年02期

6 牛金美;;健康教育在眩暈護(hù)理中的應(yīng)用[J];河北中醫(yī);2011年01期

7 ;[J];;年期

相關(guān)碩士學(xué)位論文 前1條

1 張曦;針刺治療前庭性偏頭痛（眩暈—風(fēng)陽(yáng)上擾型）的臨床研究[D];長(zhǎng)春中醫(yī)藥大學(xué);2016年

，

本文編號(hào)：1980519